Viewing Study NCT04324151


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-01-22 @ 9:16 AM
Study NCT ID: NCT04324151
Status: RECRUITING
Last Update Posted: 2024-09-19
First Post: 2020-03-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Pembrolizumab Combined With Double Platinum Based Chemotherapy for Potentially Resectable NSCLC
Sponsor: Hunan Province Tumor Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module